Who Approves Chinas Sinovac Covid19 Vaccine For Emergency Use
The World Health Organisation (Who) Has Validated The Sinovac-Coronavac Covid-19 Vaccine For Emergency Use, Giving Countries, Funders, Procuring Agencies And Communities The Assurance That It Meets International Standards For Safety, Efficacy And Manufacturing. The Vaccine Is Produced By The Beijing-Based Pharmaceutical Company Sinovac.&Ldquo;The World Desperately Needs Multiple Covid-19 Vaccines To Address The Huge Access Inequity Across The Globe,&Rdquo; Said Dr MariÂNgela SimÃO, Who Assistant-Director General For Access To Health Products. &Ldquo;We Urge Manufacturers To Participate In The Covax Facility, Share Their Knowhow And Data And Contribute To Bringing The Pandemic Under Control.&Rdquo;Who&Rsquo;S Emergency Use Listing (Eul) Is A Prerequisite For Covax Facility Vaccine Supply And International Procurement. It Also Allows Countries To Expedite Their Own Regulatory Approval To Import And Administer Covid-19 Vaccines. The Sinovac-Coronavac Product Is An Inactivated Vaccine. Its Easy Storage Requirements Make It Very Manageable And Particularly Suitable For Low-Resource Settings.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!